With the extension of artificial intelligence (AI) applications in various sectors, including medicine, scientists have taken advantage of AI algorithms (such as MHC-binding prediction tools, quantification of mutated transcript expression, and clonality of the mutation, identifying tumor-specific T cell epitopes) to predict the tumor antigens and their properties based on tumor genomic data. The gene discussed is HLA-C; the disease is neoplasm.